DEC 20, 2016 6:46 PM PST

T Cells Pushed Into Hyperdrive to Fight Viruses

WRITTEN BY: Kara Marker

As part of the immune response, T cells react differently to an acute infection versus a chronic infection, and this difference is often the heart of what makes chronic infections so hard to clear. Scientists from the La Jolla Institute for Allergy and Immunology are hoping to understand why the immune cells make different choices, in hopes that they could then tinker with their genetic makeup to fix problems.

T cells (shown in gray) attacking cancer cells.

Researchers conducted a genome-wide mapping of changes in chromatin accessibility while T cells responded to either acute or chronic infections, a series of observations that are like opening up the lid of a grand piano to see what happens on the inside when you press a key or chord of keys on the outside.

Chromatin consists of the complete population of genomic DNA sequences and their proteins. It packages and condenses DNA so genetic material take up a fraction of the space as it would completely unraveled, and chromatin also controls gene expression by opening up or closing off subsets of the genome to transcription factors. The current study used a method called ATAC-seq to identify the open areas of chromatin. By finding the subsets of the T cell genome that are open to transcription factors, ATAC-seq provides scientists the data for understanding how T cell behavior is directed through activated genes or not directed through silenced genes.

When T cells are fighting a chronic infection they appear to become “exhausted” by the continuous battle. Instead of clearing the infection like the cells do in cases of acute infection, T cells express inhibitor cell surface receptors that send inhibitory signals into the cell, halting the anti-infection attack. While this response is helpful in preventing excessive inflammation after an infection is cleared, it also prevents the continuing of an attack when a viral invader is still present. When the inhibitor signals prevent effector T cells from properly doing their job, it is called “T cell exhaustion.”

However, the study’s first author James Scott-Browne, PhD, said that thanks to their research, they “may be able to revert the exhaustion phenotype of T cells and render them better able to fight tumors or chronic viral infections such as HIV, or generate better memory cells in response to vaccines.”

Scott-Browne and the team from the La Jolla Institute for Allergy and Immunology have this potential because of their studies of transcription factors that influence both T cell activation and exhaustion. A key player is NFAT, a “molecular linchpin” that mediates between states of activation and exhaustion. T cell receptors on the surface of T cells are programmed to recognize foreign proteins, which triggers a signaling cascade that ultimately leads to the activation of NFAT and its partner AP-1.

Together, NFAT and AP-1 bind to regulatory regions in the genome that trigger T cell activation in response to cancer and viral infection. But NFAT alone binds to a different subset of regulatory regions, causing T cells to become exhausted and leading to the inhibition of the immune system response to cancer and infection

Scott-Browne’s present study builds on past studies in lab-grown T cells, this time studying T cells extracted from mice suffering either acute or chronic viral infections. They found that there are large differences in chromatin structure between naive T cells and effector T cells but hardly any difference between effector T cells and exhausted cells or memory cells, which are left behind after an infection is wiped out.

“The differences in the functions of these cell types depend mostly on the action of transcription factors that bind the already open chromatin regions,” explained co-lead author Renata Pereira. “So transcription factors could be a more interesting target to modulate the function of T cells than proteins that modulate if the chromatin is more or less accessible."

The study was recently published in the journal Immunity.

Source: La Jolla Institute for Allergy and Immunology

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog:
You May Also Like
JUL 20, 2019
JUL 20, 2019
Strep Throat Can Lead To Heart Complications
Rheumatic fever (RF) is a complication resulting from untreated strep throat. Caused by group A streptococcal infection, rheumatic fever was once the numbe...
SEP 15, 2019
SEP 15, 2019
New Observations of a Cancer Transcriptase
New research shows a transcriptase that helps time cell death varies in expression, and is unusually localized, in cancer cells.  The transcriptase, T...
OCT 16, 2019
Health & Medicine
OCT 16, 2019
Study Links High Birth Weight to Risk of Allergies
Researchers from the University of Adelaide, Australia have linked the risk of developing childhood food allergies and eczema to heavier birth weight. The...
NOV 27, 2019
Drug Discovery & Development
NOV 27, 2019
Vaccine Causes More Polio Cases than Wild Virus
The World Health Organization (WHO) has confirmed that 11 new cases of polio in five African countries including Nigeria, Congo and Angola were caused by a...
DEC 05, 2019
Drug Discovery & Development
DEC 05, 2019
New Injection that Treats Peanut Allergy
Peanut allergies affect between 1 and 3% of the US population. Associated with a heightened risk of severe anaphylactic reactions, oral immunotherapy is th...
JAN 08, 2020
Cell & Molecular Biology
JAN 08, 2020
In a First, Scientists Generate Early Human Immune Cells in the Lab
Now we know more about the early stages of the human immune system....
Loading Comments...